NextPoint Therapeutics - About the company
NextPoint Therapeutics is a series B company based in Cambridge (United States), founded in 2019. It operates as a Developer of immuno-therapeutics for cancer treatment. NextPoint Therapeutics has raised $156M in funding from investors like Bayer, Sanofi Ventures and Catalio Capital Management. The company has 3306 active competitors, including 1130 funded and 777 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.
Company Details
Developer of immuno-therapeutics for cancer treatment. It offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.
- Website
- nextpointtx.com
Key Metrics
Founded Year
2019
Location
Cambridge, United States
Stage
Series B
Total Funding
$156M in 3 rounds
Latest Funding Round
Ranked
485th among 3306 active competitors
Employee Count
10 - 49 as on Mar 01, 2026
Similar Companies
Legal entities associated with NextPoint Therapeutics
NextPoint Therapeutics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
NextPoint Therapeutics, Inc. CIN: 832332855 , United States, Active | - | 30 (As on Dec 31, 2024) | - |
Sign up to download NextPoint Therapeutics' company profile
NextPoint Therapeutics's funding and investors
NextPoint Therapeutics has raised a total funding of $156M over 3 rounds. Its first funding round was on Dec 13, 2022. NextPoint Therapeutics has 12 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of NextPoint Therapeutics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 22, 2026 | 8363139 | Series B | 3977061 | 7146022 | 3463781 | 8893392 |
Feb 14, 2024 | 9909547 | Series B | 9983633 | 4435376 | 9228908 | |
Dec 13, 2022 | 9325046 | Series B | 5145787 | 4924998 |
Access funding benchmarks and valuations. Sign up today!View details of NextPoint Therapeutics's funding rounds and investors
NextPoint Therapeutics' founders and board of directors
Founder? Claim ProfileNextPoint Therapeutics' employee count trend
NextPoint Therapeutics has 10 - 49 employees as of Mar 26. Here is NextPoint Therapeutics's employee count trend over the years:
Uncover NextPoint Therapeutics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NextPoint Therapeutics's Competitors and alternates
Top competitors of NextPoint Therapeutics include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of NextPoint Therapeutics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 80/100 | |
3rd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 73/100 | |
4th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 73/100 | |
5th | Senti Bio 2016, San Francisco (United States), Public | Developer of cell and gene therapies for patients living with incurable diseases | $158M | 72/100 | |
6th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
7th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
8th |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 71/100 | |
9th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
10th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
485th | NextPoint Therapeutics 2019, Cambridge (United States), Series B | Developer of immuno-therapeutics for cancer treatment | $156M | 53/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on NextPoint Therapeutics's competitors? Click here to see the top ones
NextPoint Therapeutics's Investments and acquisitions
NextPoint Therapeutics has made no investments or acquisitions yet.
Reports related to NextPoint Therapeutics
Here is the latest report on NextPoint Therapeutics's sector:
News related to NextPoint Therapeutics
Filter this listMedia has covered NextPoint Therapeutics for 1 event in last 1 year, It was about company updates.
•
•
NextPoint to present preclinical data on B7-H7-targeting cancer drugs at AACR.Business Wire•Apr 07, 2025•NextPoint Therapeutics
•
•
•
•
NextPoint Therapeutics Announces Closing of Series B Financing Extension Led by Catalio Capital ManagementBusiness Wire•Feb 14, 2024•NextPoint Therapeutics, Catalio Capital Management, MPM BioImpact, Bayer and 5 others
•
•
•
•
Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of DirectorsBusiness Wire•Mar 21, 2023•NextPoint Therapeutics
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about NextPoint Therapeutics
Explore our recently published companies
- Yug Global - Mumbai based, 2007 founded, Unfunded company
- Bateman Engineering - Aurora based, 1999 founded, Acquired company
- Nxtinfratrust.com - Unfunded company
- Greenhorn Wellness - Bengaluru based, 2020 founded, Unfunded company
- Infiligence - Pleasanton based, 2024 founded, Unfunded company
- Gmfoods.co.in - India based, Unfunded company
